HT
HRTX icon

Headlands Technologies’s Heron Therapeutics HRTX Stock Holding History

Headlands Technologies’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,287
Closed -$66.7K – 826
2025
Q4 		$66.7K Buy
51,287
+31,431
+158% +$38.8K 0.01% 640
2025
Q3 		$25K Sell
19,856
-63,496
-76% -$101K ﹤0.01% 593
2025
Q2 		$173K Sell
83,352
-9,206
-10% -$18.8K 0.02% 515
2025
Q1 		$204K Buy
92,558
+66,886
+261% +$130K 0.02% 456
2024
Q4 		$39.3K Sell
25,672
-24,024
-48% -$38.9K ﹤0.01% 849
2024
Q3 		$98.9K Sell
49,696
-40,799
-45% -$97.4K 0.01% 675
2024
Q2 		$317K Buy
90,495
+79,609
+731% +$245K 0.03% 375
2024
Q1 		$30.2K Buy
+10,886
New +$27.4K 0.01% 828
2023
Q3 		– Sell
-2,643
Closed -$3.07K – 1046
2023
Q2 		$3.07K Buy
+2,643
New +$4.71K ﹤0.01% 700

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return